141 related articles for article (PubMed ID: 17264777)
1. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
Moore AE; Blake GM; Fogelman I
Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
[TBL] [Abstract][Full Text] [Related]
2. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
Moore AE; Hain SF; Blake GM; Fogelman I
J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
[TBL] [Abstract][Full Text] [Related]
3. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
4. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
6. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
7. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
8. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
9. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
10. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
[TBL] [Abstract][Full Text] [Related]
11. Binding of 99mTc(113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations.
Grouls RJ; Oldenburg SJ; Savelkoul TJ; Dröge JH
Int J Rad Appl Instrum B; 1987; 14(2):127-32. PubMed ID: 3597113
[TBL] [Abstract][Full Text] [Related]
12. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
13. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
14. The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration.
Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum A; 1989; 40(7):629-35. PubMed ID: 2551860
[TBL] [Abstract][Full Text] [Related]
15. Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study.
Ozdogan O; Ertay T; Arslan G; Sisman AR; Capa Kaya G; Yilmaz O; Coker C; Gure A; Durak H
Ann Nucl Med; 2008 Jun; 22(5):357-62. PubMed ID: 18600412
[TBL] [Abstract][Full Text] [Related]
16. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
17. Influence of exercise on the distribution of technetium Tc 99m medronate following intra-articular injection in horses.
Dulin JA; Drost WT; Phelps MA; Santschi EM; Menendez MI; Bertone AL
Am J Vet Res; 2012 Mar; 73(3):418-25. PubMed ID: 22369536
[TBL] [Abstract][Full Text] [Related]
18. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants.
Sahin M; Bernay I; Basoglu T; Canturk F
Ann Nucl Med; 1999 Dec; 13(6):389-95. PubMed ID: 10656272
[TBL] [Abstract][Full Text] [Related]
20. [In vitro comparative study of plasma protein binding of 99mTc-DTPA used in renal scintigraphy].
Chemlal L; Makram S; Zoubir B; Cherrah Y; Faouzi MA
Ann Pharm Fr; 2013 Nov; 71(6):418-22. PubMed ID: 24206594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
